A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 3, 2001, Pages

  Bedford Russell, A R ^a   Emmerson, A J B ^b   Wilkinson, N ^a   Chant, T ^b   Sweet, D G ^c   Halliday, H L ^c   Holland, B ^d   Davies, E G ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ROYAL MATERNITY HOSPITAL   (United Kingdom)

^d QUEEN MOTHER S HOSPITAL   (United Kingdom)

Author keywords

Antibiotic use; Intensive care; Neutropenia; Recombinant human granulocyte colony stimulating factor; Sepsis; Very low birthweight infants

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPONATREMIA; IMMUNOTHERAPY; INFANT; MALE; MORTALITY; NEUTROPENIA; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THROMBOCYTOPENIA; VERY LOW BIRTH WEIGHT;

ANTI-INFECTIVE AGENTS; BACTEREMIA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE, NEONATAL; MALE; NEUTROPENIA; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035010418     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns
2. Exhaustion of mature marrow neutrophils in neonates with sepsis
3. Blood neutrophil response to bacterial infection in the first month of life
4. Supply and release of storage neutrophils
5. Hematologic abnormalities in severe necrotising enterocolitis
6. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells
7. Peripheral leukocyte count and leukocyte indexes in healthy and newborn term infants
8. Revised reference ranges for circulating neutrophils in very-low-birthweight neonates
9. Detection of neonatal sepsis of late onset
10. Early identification of sepsis in infants with respiratory distress
11. Late-onset neonatal sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
12. Early-onset sepsis in very low birth-weight neonates: A report from the National Institute of Child Health and Human Development Neonatal research network
13. Risk factors for chronic lung disease in the surfactant era: A North Carolina population-based study of very low birthweight infants
14. Multidrug resistance: A sign of the times
15. Novel approaches to the prevention of bacterial sepsis
16. Potential use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates
17. The in-vivo effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells
18. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia
19. Granulocyte colony stimulating factor treatment for neonatal neutropenia
20. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia
21. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia
22. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and β2 integrin expression. Results of a randomized controlled trial
23. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis
24. Sepsis syndrome and septic shock in pediatrics: Current concepts of terminology, pathophysiology and management
25. Pulmonary inflammatory cells in ventilated preterm infants: Effect of surfactant treatment
26. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance
27. Early production of macrophage inflammatory protein-1α occurs in respiratory distress syndrome and is associated with poor outcome
28. Report of working group of the British Association of Perinatal Medicine and Neonatal nurses Association on categories of babies requiring neonatal care
29. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis
30. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α